Roderick De Greef - Nov 28, 2022 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Signature
/s/ Roderick de Greef
Stock symbol
BLFS
Transactions as of
Nov 28, 2022
Transactions value $
-$939,630
Form type
4
Date filed
11/30/2022, 07:00 PM
Previous filing
Nov 23, 2022
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale -$95.5K -4.6K -5.77% $20.75 75.1K Nov 28, 2022 Direct F1, F2
transaction BLFS Common Stock Sale -$116K -5.4K -7.19% $21.44 69.7K Nov 28, 2022 Direct F1, F3
transaction BLFS Common Stock Sale -$30.3K -1.5K -2.15% $20.20 68.2K Nov 29, 2022 Direct F1, F4
transaction BLFS Common Stock Sale -$698K -33.9K -49.7% $20.59 34.3K Nov 30, 2022 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As previously disclosed, the reporting person is retiring from his position as President and Chief Operating Officer effective January 3, 2023. The reporting person is selling these shares for retirement planning.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.29 to $21.29, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.30 to $21.64, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.13 to $20.25, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.02 to $20.83, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.